Anti-HER2 CD4⁺ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer

Jashodeep Datta, Erik Berk, Shuwen Xu, Elizabeth Fitzpatrick, Cinthia Rosemblit, Lea Lowenfeld, Noah Goodman, David A Lewis, Paul J Zhang, Carla Fisher, Robert Roses, Angela DeMichele, Brian J Czerniecki
Breast Cancer Research 2015, 17:71 (23 May 2015)